nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—SLC22A2—nephron—nephrolithiasis	0.0462	0.213	CbGeAlD
Prazosin—KCNH6—nephron tubule—nephrolithiasis	0.0168	0.0779	CbGeAlD
Prazosin—KCNH6—renal system—nephrolithiasis	0.0153	0.0708	CbGeAlD
Prazosin—KCNH6—kidney—nephrolithiasis	0.0148	0.0685	CbGeAlD
Prazosin—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0139	0.0535	CcSEcCtD
Prazosin—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0416	CcSEcCtD
Prazosin—SLC22A2—nephron tubule—nephrolithiasis	0.00996	0.0461	CbGeAlD
Prazosin—SLC22A2—renal system—nephrolithiasis	0.00906	0.0419	CbGeAlD
Prazosin—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00898	0.0346	CcSEcCtD
Prazosin—SLC22A2—kidney—nephrolithiasis	0.00876	0.0405	CbGeAlD
Prazosin—ADRA1B—renal system—nephrolithiasis	0.00867	0.0401	CbGeAlD
Prazosin—SLC22A2—cortex of kidney—nephrolithiasis	0.00853	0.0394	CbGeAlD
Prazosin—ADRA1B—kidney—nephrolithiasis	0.00838	0.0388	CbGeAlD
Prazosin—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00833	0.0321	CcSEcCtD
Prazosin—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00828	0.0319	CcSEcCtD
Prazosin—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00785	0.0303	CcSEcCtD
Prazosin—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00783	0.0302	CcSEcCtD
Prazosin—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00715	0.0275	CcSEcCtD
Prazosin—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00692	0.0267	CcSEcCtD
Prazosin—SLC22A1—renal system—nephrolithiasis	0.0064	0.0296	CbGeAlD
Prazosin—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00634	0.0244	CcSEcCtD
Prazosin—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00631	0.0243	CcSEcCtD
Prazosin—SLC22A1—kidney—nephrolithiasis	0.00619	0.0286	CbGeAlD
Prazosin—HTR1D—kidney—nephrolithiasis	0.00613	0.0283	CbGeAlD
Prazosin—SLC22A3—renal system—nephrolithiasis	0.00611	0.0283	CbGeAlD
Prazosin—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00601	0.0232	CcSEcCtD
Prazosin—SLC22A3—kidney—nephrolithiasis	0.00591	0.0273	CbGeAlD
Prazosin—Tension—Hydrochlorothiazide—nephrolithiasis	0.00581	0.0224	CcSEcCtD
Prazosin—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00575	0.0222	CcSEcCtD
Prazosin—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00558	0.0215	CcSEcCtD
Prazosin—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00549	0.0212	CcSEcCtD
Prazosin—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00534	0.0206	CcSEcCtD
Prazosin—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00532	0.0205	CcSEcCtD
Prazosin—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00531	0.0205	CcSEcCtD
Prazosin—HTR1A—renal system—nephrolithiasis	0.00528	0.0244	CbGeAlD
Prazosin—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00523	0.0202	CcSEcCtD
Prazosin—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.0052	0.0201	CcSEcCtD
Prazosin—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00504	0.0194	CcSEcCtD
Prazosin—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00498	0.0192	CcSEcCtD
Prazosin—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00493	0.019	CcSEcCtD
Prazosin—ADRA1A—renal system—nephrolithiasis	0.00487	0.0225	CbGeAlD
Prazosin—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00483	0.0186	CcSEcCtD
Prazosin—Shock—Hydrochlorothiazide—nephrolithiasis	0.00475	0.0183	CcSEcCtD
Prazosin—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00472	0.0182	CcSEcCtD
Prazosin—KCNH2—renal system—nephrolithiasis	0.0047	0.0218	CbGeAlD
Prazosin—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00467	0.018	CcSEcCtD
Prazosin—ABCG2—nephron tubule—nephrolithiasis	0.0046	0.0213	CbGeAlD
Prazosin—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.0044	0.017	CcSEcCtD
Prazosin—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00437	0.0168	CcSEcCtD
Prazosin—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00434	0.0167	CcSEcCtD
Prazosin—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00431	0.0166	CcSEcCtD
Prazosin—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.0043	0.0166	CcSEcCtD
Prazosin—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00417	0.0161	CcSEcCtD
Prazosin—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00413	0.0159	CcSEcCtD
Prazosin—Pain—Hydrochlorothiazide—nephrolithiasis	0.00413	0.0159	CcSEcCtD
Prazosin—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00398	0.0153	CcSEcCtD
Prazosin—CYP1A1—renal system—nephrolithiasis	0.00397	0.0184	CbGeAlD
Prazosin—CYP1A1—kidney—nephrolithiasis	0.00384	0.0178	CbGeAlD
Prazosin—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00384	0.0148	CcSEcCtD
Prazosin—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00382	0.0147	CcSEcCtD
Prazosin—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00356	0.0137	CcSEcCtD
Prazosin—ADRA2A—cortex of kidney—nephrolithiasis	0.00349	0.0161	CbGeAlD
Prazosin—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00347	0.0134	CcSEcCtD
Prazosin—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00342	0.0132	CcSEcCtD
Prazosin—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00331	0.0127	CcSEcCtD
Prazosin—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.0032	0.0123	CcSEcCtD
Prazosin—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00307	0.0118	CcSEcCtD
Prazosin—Rash—Hydrochlorothiazide—nephrolithiasis	0.00305	0.0117	CcSEcCtD
Prazosin—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00304	0.0117	CcSEcCtD
Prazosin—Headache—Hydrochlorothiazide—nephrolithiasis	0.00303	0.0117	CcSEcCtD
Prazosin—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00287	0.0111	CcSEcCtD
Prazosin—ABCB1—nephron tubule—nephrolithiasis	0.00227	0.0105	CbGeAlD
Prazosin—ABCB1—renal system—nephrolithiasis	0.00206	0.00955	CbGeAlD
Prazosin—ABCB1—kidney—nephrolithiasis	0.002	0.00923	CbGeAlD
Prazosin—ABCB1—cortex of kidney—nephrolithiasis	0.00194	0.00899	CbGeAlD
Prazosin—ADRA1A—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00193	0.00368	CbGpPWpGaD
Prazosin—ADRA1D—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00189	0.00361	CbGpPWpGaD
Prazosin—ADRA1B—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00188	0.00359	CbGpPWpGaD
Prazosin—CYP1A1—Biological oxidations—SLC26A1—nephrolithiasis	0.00186	0.00355	CbGpPWpGaD
Prazosin—SLC22A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00182	0.00347	CbGpPWpGaD
Prazosin—SLC22A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00182	0.00347	CbGpPWpGaD
Prazosin—ABCG2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00175	0.00333	CbGpPWpGaD
Prazosin—ABCG2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00175	0.00333	CbGpPWpGaD
Prazosin—SLC22A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00174	0.00332	CbGpPWpGaD
Prazosin—SLC22A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00173	0.0033	CbGpPWpGaD
Prazosin—SLC22A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00173	0.0033	CbGpPWpGaD
Prazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00172	0.00329	CbGpPWpGaD
Prazosin—HTR1D—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00171	0.00326	CbGpPWpGaD
Prazosin—SLC22A3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.0017	0.00325	CbGpPWpGaD
Prazosin—SLC22A3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.0017	0.00325	CbGpPWpGaD
Prazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00169	0.00323	CbGpPWpGaD
Prazosin—ADRA1A—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00167	0.00319	CbGpPWpGaD
Prazosin—SLC22A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00162	0.0031	CbGpPWpGaD
Prazosin—SLC22A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00161	0.00307	CbGpPWpGaD
Prazosin—SLC22A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00161	0.00307	CbGpPWpGaD
Prazosin—SLC22A3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00158	0.00302	CbGpPWpGaD
Prazosin—SLC22A3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00158	0.00302	CbGpPWpGaD
Prazosin—ADRA1B—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00157	0.00299	CbGpPWpGaD
Prazosin—ADRA2A—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00157	0.00299	CbGpPWpGaD
Prazosin—ABCG2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00156	0.00297	CbGpPWpGaD
Prazosin—SLC22A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00154	0.00294	CbGpPWpGaD
Prazosin—HTR1D—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00146	0.00279	CbGpPWpGaD
Prazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00146	0.00279	CbGpPWpGaD
Prazosin—SLC22A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00144	0.00274	CbGpPWpGaD
Prazosin—ABCG2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00142	0.00272	CbGpPWpGaD
Prazosin—ABCG2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00142	0.00272	CbGpPWpGaD
Prazosin—SLC22A3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00141	0.00269	CbGpPWpGaD
Prazosin—SLC22A3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00141	0.00269	CbGpPWpGaD
Prazosin—SLC22A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00141	0.00269	CbGpPWpGaD
Prazosin—SLC22A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00141	0.00269	CbGpPWpGaD
Prazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.0014	0.00268	CbGpPWpGaD
Prazosin—ADRA1A—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00139	0.00266	CbGpPWpGaD
Prazosin—ADRA2B—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00132	0.00252	CbGpPWpGaD
Prazosin—SLC22A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00131	0.00251	CbGpPWpGaD
Prazosin—SLC22A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00131	0.00251	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—RGS14—nephrolithiasis	0.00129	0.00246	CbGpPWpGaD
Prazosin—HTR1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00127	0.00243	CbGpPWpGaD
Prazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00125	0.00239	CbGpPWpGaD
Prazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00125	0.00238	CbGpPWpGaD
Prazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00121	0.00231	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—RGS14—nephrolithiasis	0.00117	0.00223	CbGpPWpGaD
Prazosin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00113	0.00216	CbGpPWpGaD
Prazosin—SLC22A3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00113	0.00215	CbGpPWpGaD
Prazosin—HTR1D—GPCR ligand binding—CHRM3—nephrolithiasis	0.00111	0.00212	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—RGS14—nephrolithiasis	0.0011	0.0021	CbGpPWpGaD
Prazosin—HTR1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00109	0.00208	CbGpPWpGaD
Prazosin—ABCG2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00108	0.00206	CbGpPWpGaD
Prazosin—ABCG2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00108	0.00206	CbGpPWpGaD
Prazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00108	0.00206	CbGpPWpGaD
Prazosin—SLC22A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00107	0.00204	CbGpPWpGaD
Prazosin—SLC22A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00107	0.00204	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—SLC7A9—nephrolithiasis	0.00106	0.00203	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—DGKH—nephrolithiasis	0.00106	0.00203	CbGpPWpGaD
Prazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00104	0.00198	CbGpPWpGaD
Prazosin—HTR1D—GPCR ligand binding—PTH—nephrolithiasis	0.00102	0.00194	CbGpPWpGaD
Prazosin—ABCG2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.001	0.00191	CbGpPWpGaD
Prazosin—ABCG2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.001	0.00191	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—RGS14—nephrolithiasis	0.001	0.00191	CbGpPWpGaD
Prazosin—ADRA2A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.001	0.00191	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—RGS14—nephrolithiasis	0.000996	0.0019	CbGpPWpGaD
Prazosin—SLC22A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000996	0.0019	CbGpPWpGaD
Prazosin—SLC22A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000996	0.0019	CbGpPWpGaD
Prazosin—SLC22A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000993	0.00189	CbGpPWpGaD
Prazosin—SLC22A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000993	0.00189	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—GRHPR—nephrolithiasis	0.000979	0.00187	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000962	0.00183	CbGpPWpGaD
Prazosin—ADRA1D—GPCR ligand binding—CHRM3—nephrolithiasis	0.000954	0.00182	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000945	0.0018	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000945	0.0018	CbGpPWpGaD
Prazosin—SLC22A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000926	0.00177	CbGpPWpGaD
Prazosin—SLC22A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000926	0.00177	CbGpPWpGaD
Prazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000923	0.00176	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—RGS14—nephrolithiasis	0.000916	0.00175	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—RGS14—nephrolithiasis	0.000905	0.00173	CbGpPWpGaD
Prazosin—ABCG2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000895	0.00171	CbGpPWpGaD
Prazosin—ABCG2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000895	0.00171	CbGpPWpGaD
Prazosin—SLC22A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000885	0.00169	CbGpPWpGaD
Prazosin—SLC22A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000885	0.00169	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—RGS14—nephrolithiasis	0.000873	0.00167	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—AGXT—nephrolithiasis	0.000872	0.00166	CbGpPWpGaD
Prazosin—ADRA1D—GPCR ligand binding—PTH—nephrolithiasis	0.000872	0.00166	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—DGKH—nephrolithiasis	0.000871	0.00166	CbGpPWpGaD
Prazosin—ADRA2B—GPCR ligand binding—CHRM3—nephrolithiasis	0.000861	0.00164	CbGpPWpGaD
Prazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000858	0.00164	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000842	0.00161	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—RGS14—nephrolithiasis	0.000832	0.00159	CbGpPWpGaD
Prazosin—HTR1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000831	0.00159	CbGpPWpGaD
Prazosin—SLC22A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000825	0.00157	CbGpPWpGaD
Prazosin—SLC22A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000825	0.00157	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000814	0.00155	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—ADCY10—nephrolithiasis	0.000814	0.00155	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—SLC7A9—nephrolithiasis	0.000808	0.00154	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—DGKH—nephrolithiasis	0.000808	0.00154	CbGpPWpGaD
Prazosin—ADRA1B—GPCR ligand binding—CHRM3—nephrolithiasis	0.000792	0.00151	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—DGKH—nephrolithiasis	0.000791	0.00151	CbGpPWpGaD
Prazosin—ADRA2B—GPCR ligand binding—PTH—nephrolithiasis	0.000787	0.0015	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00077	0.00147	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00077	0.00147	CbGpPWpGaD
Prazosin—HTR1A—GPCR ligand binding—PTH—nephrolithiasis	0.00076	0.00145	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000756	0.00144	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—DGKH—nephrolithiasis	0.000745	0.00142	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—APRT—nephrolithiasis	0.000742	0.00141	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—SLC26A1—nephrolithiasis	0.000742	0.00141	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—RGS14—nephrolithiasis	0.000739	0.00141	CbGpPWpGaD
Prazosin—ADRA1B—GPCR ligand binding—PTH—nephrolithiasis	0.000724	0.00138	CbGpPWpGaD
Prazosin—ABCG2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000715	0.00136	CbGpPWpGaD
Prazosin—SLC22A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000708	0.00135	CbGpPWpGaD
Prazosin—ADRA1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000703	0.00134	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—ADCY10—nephrolithiasis	0.000696	0.00133	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—RGS14—nephrolithiasis	0.000692	0.00132	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—RGS14—nephrolithiasis	0.000686	0.00131	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—DGKH—nephrolithiasis	0.000677	0.00129	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—DGKH—nephrolithiasis	0.000673	0.00128	CbGpPWpGaD
Prazosin—SLC22A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00066	0.00126	CbGpPWpGaD
Prazosin—ADRA2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000653	0.00125	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00065	0.00124	CbGpPWpGaD
Prazosin—ADRA1A—GPCR ligand binding—PTH—nephrolithiasis	0.000643	0.00123	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00063	0.0012	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—ADCY10—nephrolithiasis	0.000629	0.0012	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—GRHPR—nephrolithiasis	0.00062	0.00118	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—DGKH—nephrolithiasis	0.000619	0.00118	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—GRHPR—nephrolithiasis	0.000614	0.00117	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—DGKH—nephrolithiasis	0.000611	0.00117	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—ADCY10—nephrolithiasis	0.000607	0.00116	CbGpPWpGaD
Prazosin—ADRA2A—GPCR ligand binding—PTH—nephrolithiasis	0.000597	0.00114	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—RGS14—nephrolithiasis	0.000592	0.00113	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—DGKH—nephrolithiasis	0.00059	0.00113	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000584	0.00111	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000584	0.00111	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—ADCY10—nephrolithiasis	0.000578	0.0011	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—PTH—nephrolithiasis	0.000576	0.0011	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—GRHPR—nephrolithiasis	0.000572	0.00109	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—CHRM3—nephrolithiasis	0.000572	0.00109	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—DGKH—nephrolithiasis	0.000562	0.00107	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—AGXT—nephrolithiasis	0.000553	0.00105	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00055	0.00105	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—AGXT—nephrolithiasis	0.000547	0.00104	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000543	0.00103	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000543	0.00103	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000539	0.00103	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—RGS14—nephrolithiasis	0.000534	0.00102	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—AQP1—nephrolithiasis	0.000529	0.00101	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—PTH—nephrolithiasis	0.000523	0.000997	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—RGS14—nephrolithiasis	0.000516	0.000984	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—ADCY10—nephrolithiasis	0.000513	0.000979	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000511	0.000974	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—AGXT—nephrolithiasis	0.00051	0.000973	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—DGKH—nephrolithiasis	0.000499	0.000952	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—PTH—nephrolithiasis	0.000493	0.00094	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—RGS14—nephrolithiasis	0.000491	0.000937	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—CHRM3—nephrolithiasis	0.000489	0.000933	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000487	0.000928	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—GRHPR—nephrolithiasis	0.000485	0.000925	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000484	0.000922	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000484	0.000922	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—CHRM3—nephrolithiasis	0.000478	0.000912	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—ADCY10—nephrolithiasis	0.000477	0.00091	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—APRT—nephrolithiasis	0.00047	0.000896	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—SLC26A1—nephrolithiasis	0.00047	0.000896	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00047	0.000896	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—DGKH—nephrolithiasis	0.000467	0.000891	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000467	0.000891	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—SLC26A1—nephrolithiasis	0.000465	0.000887	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—APRT—nephrolithiasis	0.000465	0.000887	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—DGKH—nephrolithiasis	0.000464	0.000884	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—PTH—nephrolithiasis	0.000448	0.000854	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000447	0.000853	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—PTH—nephrolithiasis	0.000445	0.000849	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—CHRM3—nephrolithiasis	0.000442	0.000843	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—RGS14—nephrolithiasis	0.000436	0.000832	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—APRT—nephrolithiasis	0.000434	0.000827	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—SLC26A1—nephrolithiasis	0.000434	0.000827	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—AGXT—nephrolithiasis	0.000432	0.000824	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—PTH—nephrolithiasis	0.00043	0.000819	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000427	0.000813	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—GRHPR—nephrolithiasis	0.00042	0.000801	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—PTH—nephrolithiasis	0.000409	0.00078	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—CHRM3—nephrolithiasis	0.000406	0.000775	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—RGS14—nephrolithiasis	0.000406	0.000773	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—PTH—nephrolithiasis	0.000404	0.000771	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.0004	0.000763	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—DGKH—nephrolithiasis	0.0004	0.000763	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000397	0.000758	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—PTH—nephrolithiasis	0.00039	0.000744	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000387	0.000737	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—AGXT—nephrolithiasis	0.000374	0.000714	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—PTH—nephrolithiasis	0.000372	0.000709	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000369	0.000704	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—SLC26A1—nephrolithiasis	0.000368	0.000701	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—APRT—nephrolithiasis	0.000368	0.000701	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—PTH—nephrolithiasis	0.000363	0.000693	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—DGKH—nephrolithiasis	0.000361	0.000688	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000361	0.000688	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000361	0.000688	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—DGKH—nephrolithiasis	0.000349	0.000665	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000349	0.000665	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CHRM3—nephrolithiasis	0.000338	0.000644	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—PTH—nephrolithiasis	0.000338	0.000644	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000335	0.00064	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000335	0.000639	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—AQP1—nephrolithiasis	0.000335	0.000639	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000332	0.000633	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—DGKH—nephrolithiasis	0.000332	0.000633	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—AQP1—nephrolithiasis	0.000331	0.000632	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—PTH—nephrolithiasis	0.00033	0.000629	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—APRT—nephrolithiasis	0.000318	0.000607	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—SLC26A1—nephrolithiasis	0.000318	0.000607	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—AQP1—nephrolithiasis	0.000309	0.000589	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—PTH—nephrolithiasis	0.000309	0.000589	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—PTH—nephrolithiasis	0.000307	0.000585	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—CHRM3—nephrolithiasis	0.000303	0.000578	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—CHRM3—nephrolithiasis	0.0003	0.000572	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000299	0.00057	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000295	0.000562	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—DGKH—nephrolithiasis	0.000295	0.000562	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CHRM3—nephrolithiasis	0.000289	0.000551	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—CHRM3—nephrolithiasis	0.000279	0.000533	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—DGKH—nephrolithiasis	0.000274	0.000522	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000274	0.000522	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—PTH—nephrolithiasis	0.000264	0.000504	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—AQP1—nephrolithiasis	0.000262	0.000499	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CHRM3—nephrolithiasis	0.000261	0.000498	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000254	0.000485	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—APRT—nephrolithiasis	0.000254	0.000485	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CHRM3—nephrolithiasis	0.000252	0.000481	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CHRM3—nephrolithiasis	0.00024	0.000458	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—PTH—nephrolithiasis	0.000239	0.000455	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—CHRM3—nephrolithiasis	0.000237	0.000452	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—PTH—nephrolithiasis	0.00023	0.000439	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—AQP1—nephrolithiasis	0.000227	0.000432	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PTH—nephrolithiasis	0.000219	0.000419	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CHRM3—nephrolithiasis	0.000213	0.000406	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—CHRM3—nephrolithiasis	0.000205	0.000391	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CHRM3—nephrolithiasis	0.000198	0.000378	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PTH—nephrolithiasis	0.000195	0.000372	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PTH—nephrolithiasis	0.000181	0.000345	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—AQP1—nephrolithiasis	0.000181	0.000345	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CHRM3—nephrolithiasis	0.000164	0.000312	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—SPP1—nephrolithiasis	0.000155	0.000296	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—SPP1—nephrolithiasis	0.000133	0.000253	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—SPP1—nephrolithiasis	0.00012	0.000229	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—SPP1—nephrolithiasis	0.000116	0.000221	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—SPP1—nephrolithiasis	0.00011	0.00021	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—SPP1—nephrolithiasis	9.79e-05	0.000187	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—SPP1—nephrolithiasis	9.09e-05	0.000173	CbGpPWpGaD
